Follow us on:

Linkedin Facebook

News

Oxford Nanopore CEO Gordon Sanghera to step down

Oxford Nanopore has announced that CEO and co-founder Gordon Sanghera will step down by the end of 2026 after more than 20 years leading the company. The Board has begun a formal search for his successor as part of its succession planning, aiming to guide the business through its next phase of growth and commercialisation...
GSK

GSK’s Gepotidacin receives US FDA Priority Review for gonorrhoea treatment

GSK has announced that the US FDA has accepted for priority review a supplemental New Drug Application for gepotidacin as an oral treatment for uncomplicated urogenital gonorrhoea in patients aged 12 and over...
Nuformix

Nuformix applies for US Orphan Drug Designation for NXP002 in IPF

Nuformix has submitted an application to the US FDA for Orphan Drug Designation for tranilast, the active ingredient in its NXP002 inhaled therapy for idiopathic pulmonary fibrosis...
Dekel Agri-Vision

Dekel Agri-Vision sees record cashew output, higher palm oil prices

Dekel Agri-Vision has announced a July 2025 update, highlighting record monthly raw cashew nut processing of 533 tonnes at its Tiebissou plant, up 423% from July 2024...
Diversified Energy Company

Diversified Energy delivers strong H1 2025 with Carlyle partnership boost

Diversified Energy Company posted first-half 2025 results in line with expectations, delivering strong production growth, improved financial metrics, and $152 million in adjusted free cash flow..
EDX Medical Group plc

EDX Medical Group to complete the development of new pneumonia test

EDX Medical will partner with the Intensive Care Unit at Cambridge University Hospitals NHS Foundation Trust to support the further advancement of a highly precise test that identifies the DNA or RNA of the microbes that cause lung infection in critically ill patients...
TBC Bank Group

TBC Bank Group declares 2Q 2025 dividend of GEL 1.75 per share

TBC Bank Group PLC has announced a quarterly dividend of GEL 1.75 per share for 2Q 2025, payable in Pounds Sterling...
GSK plc

GSK to receive $370m settlement and royalties from mRNA patent agreement

GSK will receive a $370 million upfront payment, plus 1% royalties on US sales of certain mRNA vaccines by BioNTech and Pfizer, following a settlement linked to CureVac’s recent agreement with BioNTech...
Union Jack Oil plc

Union Jack Oil director increases shareholding

Union Jack Oil Non-Executive Director Craig Howie has acquired 122,000 shares at 5.075 pence each, raising his total holding to 3,377,000 shares, representing 2.21% of the company’s issued share capital...
Aptamer Group

Aptamer Group to host technical development update webinar

Aptamer will hold a webinar on 14 August 2025 at 6:00 pm BST, led by Chief Scientific Officer Dr David Bunka, to present the latest data and progress across its technical development programmes...
Hikma Pharmaceuticals plc

Hikma Pharmaceuticals reports 6% revenue growth and confirms FY outlook

Hikma Pharmaceuticals posted a 6% rise in H1 2025 revenue to $1.66 billion, supported by strong Injectables and Branded sales. Core operating profit declined 7% due to product mix and prior-year comparators, but the company expects a stronger H2...
Valeura Energy

Valeura Energy reports $50.5m Q2 cashflow and expands Thai operations

Valeura Energy reported Q2 2025 oil production of 21,412 bbls/d and US$50.5 million in after-tax cashflow from operations. The company reaffirmed 2025 guidance and confirmed strong liquidity with US$242 million in cash and no debt. Key developments include final investment decision on the Wassana redevelopment and a new farm-in agreement with PTTEP, expanding Valeura’s Gulf of Thailand footprint nearly tenfold...
REACT Group

REACT Group reports new contract wins across all divisions

REACT Group has announced a series of contract wins since April 2025 across all four divisions, including specialist cleaning, drainage, and facilities services. New clients include NHS Trusts, H&M, BP Forecourts, and Homes England, supporting the Group’s cross-selling strategy and revenue growth objectives...
Likewise

Likewise Group raises £1.4m to support growth strategy

Likewise Group has secured approximately £1.4 million through a subscription of 5.5 million new shares by Onward Opportunities. The funding will be used to accelerate future growth initiatives, with shares admitted to trading on AIM from 11 August 2025...
Union Jack Oil plc

Union Jack Oil explores Bitcoin mining to monetise West Newton gas

Union Jack Oil has announced early-stage plans to monetise gas from its West Newton discovery by powering on-site Bitcoin mining operations. A non-binding LOI has been signed with Texas-based 360 Energy to develop a gas-to-crypto solution, aiming to generate near-term revenue while full field development progresses...

TEAM plc Mark Clubb Executive Chairman Sets Sights on £2 billion as UCITS Launch Fuels Global Growth

TEAM plc Executive Chairman Mark Clubb has given an interview with DirectorsTalk, outlining the firm’s UCITS fund launch, HY25 interim results, and future outlook...
Sirius Real Estate

Sirius Real Estate adds German and UK business parks in €40m off-market deals

Sirius Real Estate has acquired a €23.4m site in Dresden and completed the £16.13m purchase of Bedford Heights, both secured off-market. The assets offer strong yields of over 9% and align with Sirius’ strategy of targeting income-generating properties with value-add potential in high-demand sectors and regions...
Tritax Big Box REIT

Tritax Big Box REIT reports strong H1 performance with 17% rental income growth

Tritax Big Box REIT delivered 17.3% growth in net rental income to £149.2m for H1 2025, with adjusted EPS up 6.4%. Backed by logistics and data centre developments, the company sees potential to grow adjusted earnings by 50% by 2030. Disposals of £278m year-to-date support its strategy of self-funded growth...
Hiscox Ltd

Hiscox Ltd reports profitable growth across all divisions in H1 2025

Hiscox delivered 5.7% growth in written premiums to $2.94bn and maintained strong profitability with a 92.6% combined ratio. Retail margins expanded, investment income rose to $234.9m, and operating return on tangible equity reached 14.5%...
Legal & General

Legal & General grows core EPS by 9% as strategic focus strengthens

Legal & General reported a 9% rise in core operating EPS and a 6% increase in core operating profit to £859m for H1 2025. The group recorded £5.2bn of new Institutional Retirement business and grew Workplace pension assets to over £100bn...
Load More

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

Green News

View all Sustainable sectors, Plcs and news >>  

Search

Search

Latest Interviews

BrokerTalk

Funds

View all Funds, Market Insights and news >> 

FTSE 100 News

UK Broker Ratings

News

Oxford Nanopore CEO Gordon Sanghera to step down

Oxford Nanopore has announced that CEO and co-founder Gordon Sanghera will step down by the end of 2026 after more than 20 years leading the company. The Board has begun a formal search for his successor as part of its succession planning, aiming to guide the business through its next phase of growth and commercialisation...
GSK

GSK’s Gepotidacin receives US FDA Priority Review for gonorrhoea treatment

GSK has announced that the US FDA has accepted for priority review a supplemental New Drug Application for gepotidacin as an oral treatment for uncomplicated urogenital gonorrhoea in patients aged 12 and over...
Nuformix

Nuformix applies for US Orphan Drug Designation for NXP002 in IPF

Nuformix has submitted an application to the US FDA for Orphan Drug Designation for tranilast, the active ingredient in its NXP002 inhaled therapy for idiopathic pulmonary fibrosis...
Dekel Agri-Vision

Dekel Agri-Vision sees record cashew output, higher palm oil prices

Dekel Agri-Vision has announced a July 2025 update, highlighting record monthly raw cashew nut processing of 533 tonnes at its Tiebissou plant, up 423% from July 2024...
Diversified Energy Company

Diversified Energy delivers strong H1 2025 with Carlyle partnership boost

Diversified Energy Company posted first-half 2025 results in line with expectations, delivering strong production growth, improved financial metrics, and $152 million in adjusted free cash flow..
EDX Medical Group plc

EDX Medical Group to complete the development of new pneumonia test

EDX Medical will partner with the Intensive Care Unit at Cambridge University Hospitals NHS Foundation Trust to support the further advancement of a highly precise test that identifies the DNA or RNA of the microbes that cause lung infection in critically ill patients...
TBC Bank Group

TBC Bank Group declares 2Q 2025 dividend of GEL 1.75 per share

TBC Bank Group PLC has announced a quarterly dividend of GEL 1.75 per share for 2Q 2025, payable in Pounds Sterling...
GSK plc

GSK to receive $370m settlement and royalties from mRNA patent agreement

GSK will receive a $370 million upfront payment, plus 1% royalties on US sales of certain mRNA vaccines by BioNTech and Pfizer, following a settlement linked to CureVac’s recent agreement with BioNTech...
Union Jack Oil plc

Union Jack Oil director increases shareholding

Union Jack Oil Non-Executive Director Craig Howie has acquired 122,000 shares at 5.075 pence each, raising his total holding to 3,377,000 shares, representing 2.21% of the company’s issued share capital...
Aptamer Group

Aptamer Group to host technical development update webinar

Aptamer will hold a webinar on 14 August 2025 at 6:00 pm BST, led by Chief Scientific Officer Dr David Bunka, to present the latest data and progress across its technical development programmes...
Hikma Pharmaceuticals plc

Hikma Pharmaceuticals reports 6% revenue growth and confirms FY outlook

Hikma Pharmaceuticals posted a 6% rise in H1 2025 revenue to $1.66 billion, supported by strong Injectables and Branded sales. Core operating profit declined 7% due to product mix and prior-year comparators, but the company expects a stronger H2...
Valeura Energy

Valeura Energy reports $50.5m Q2 cashflow and expands Thai operations

Valeura Energy reported Q2 2025 oil production of 21,412 bbls/d and US$50.5 million in after-tax cashflow from operations. The company reaffirmed 2025 guidance and confirmed strong liquidity with US$242 million in cash and no debt. Key developments include final investment decision on the Wassana redevelopment and a new farm-in agreement with PTTEP, expanding Valeura’s Gulf of Thailand footprint nearly tenfold...
REACT Group

REACT Group reports new contract wins across all divisions

REACT Group has announced a series of contract wins since April 2025 across all four divisions, including specialist cleaning, drainage, and facilities services. New clients include NHS Trusts, H&M, BP Forecourts, and Homes England, supporting the Group’s cross-selling strategy and revenue growth objectives...
Likewise

Likewise Group raises £1.4m to support growth strategy

Likewise Group has secured approximately £1.4 million through a subscription of 5.5 million new shares by Onward Opportunities. The funding will be used to accelerate future growth initiatives, with shares admitted to trading on AIM from 11 August 2025...
Union Jack Oil plc

Union Jack Oil explores Bitcoin mining to monetise West Newton gas

Union Jack Oil has announced early-stage plans to monetise gas from its West Newton discovery by powering on-site Bitcoin mining operations. A non-binding LOI has been signed with Texas-based 360 Energy to develop a gas-to-crypto solution, aiming to generate near-term revenue while full field development progresses...

TEAM plc Mark Clubb Executive Chairman Sets Sights on £2 billion as UCITS Launch Fuels Global Growth

TEAM plc Executive Chairman Mark Clubb has given an interview with DirectorsTalk, outlining the firm’s UCITS fund launch, HY25 interim results, and future outlook...
Sirius Real Estate

Sirius Real Estate adds German and UK business parks in €40m off-market deals

Sirius Real Estate has acquired a €23.4m site in Dresden and completed the £16.13m purchase of Bedford Heights, both secured off-market. The assets offer strong yields of over 9% and align with Sirius’ strategy of targeting income-generating properties with value-add potential in high-demand sectors and regions...
Tritax Big Box REIT

Tritax Big Box REIT reports strong H1 performance with 17% rental income growth

Tritax Big Box REIT delivered 17.3% growth in net rental income to £149.2m for H1 2025, with adjusted EPS up 6.4%. Backed by logistics and data centre developments, the company sees potential to grow adjusted earnings by 50% by 2030. Disposals of £278m year-to-date support its strategy of self-funded growth...
Hiscox Ltd

Hiscox Ltd reports profitable growth across all divisions in H1 2025

Hiscox delivered 5.7% growth in written premiums to $2.94bn and maintained strong profitability with a 92.6% combined ratio. Retail margins expanded, investment income rose to $234.9m, and operating return on tangible equity reached 14.5%...
Legal & General

Legal & General grows core EPS by 9% as strategic focus strengthens

Legal & General reported a 9% rise in core operating EPS and a 6% increase in core operating profit to £859m for H1 2025. The group recorded £5.2bn of new Institutional Retirement business and grew Workplace pension assets to over £100bn...
Load More

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

Green News

View all Sustainable sectors, Plcs and news >>  

Search

Search

Latest interviews

Broker Talk

Funds

View all Funds, Market Insights and news >> 

FTSE 100 News

UK Broker Ratings

News

Latest Interviews

FTSE 100 News

FTSE 250 News

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

BrokerTalk

FTSE 100

Funds

View all Funds, Market Insights and news >> 

Green News

View all Sustainable sectors, Plcs and news >>  

UK Broker Ratings

Useful links

Disclaimer

You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.

© 2025 – DirectorsTalk Interviews. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.

Follow us on Social Media:

Home X-twitter Linkedin Facebook Spotify Apple